MapLight Therapeutics, Inc. (MPLT)
NASDAQ: MPLT · Real-Time Price · USD
29.76
+0.65 (2.23%)
At close: Apr 24, 2026, 4:00 PM EDT
29.49
-0.27 (-0.91%)
After-hours: Apr 24, 2026, 7:24 PM EDT
MapLight Therapeutics Market Cap
MapLight Therapeutics has a market cap or net worth of $1.31 billion as of April 24, 2026.
Market Cap
1.31B
Enterprise Value
1.01B
1-Year Change
n/a
Ranking
Category
Stock Price
$29.76
Market Cap Chart
Since the IPO on October 27, 2025, MapLight Therapeutics's market cap has increased from $704.29M to $1.31B, an increase of 86.02%. That is a compound annual growth rate of 254.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2026 | 1.31B | 70.91% |
| Dec 31, 2025 | 766.56M | 8.84% |
| Oct 27, 2025 | 704.29M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Viridian Therapeutics | 1.42B |
| Wave Life Sciences | 1.38B |
| Olema Pharmaceuticals | 1.35B |
| Corvus Pharmaceuticals | 1.35B |
| ArriVent BioPharma | 1.34B |
| Novavax | 1.34B |
| Savara | 1.30B |
| AbCellera Biologics | 1.26B |